Answers are grounded in this paper and cite their sources.
The Cambridge Multimorbidity Score is robust and can be either tailored or not tailored to specific health outcomes. It will be valuable to those planning clinical services, policymakers allocating resources and researchers seeking to account for the effect of multimorbidity.
No takes yet. Share an insight, caveat, or question.
Payne et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: